Life Sciences

The Ecosystem IQ

Unlocking the ecosystem paradox to drive business model innovation and digital growth

Innovation in Market Access: winning approaches to secure commercial success

The Market Access function in pharmaceutical and other medical technology companies has reached a stage of maturity, and professionals now want to take a step back, explore best practices and identify the best approach to innovation.

When IT/Tech breaks the deal - How to avoid pitfalls in IT and Tech when selling companies

During this breakfast seminar we will present and discuss around common IT and Tech specific challenges and pitfalls in connection with M&A transactions - both for pure tech companies but also for the IT function of “normal” companies.

Generating growth based on evidence-driven analysis and a continuous focus on quality

BearingPoint conducted a structured, evidence-based approach to evaluate potential markets that met Mercodias growth requirements. As a result, they decided to pursue a new market.

BearingPoint acquires Inpuls, a leading data specialist in Belgium

The acquisition contributes to BearingPoint’s overall growth objectives, strengthens its presence in Belgium, and enhances its data capabilities.

Re-thinking the European Business Model Portfolio for the Digital Age

CEOs and Boards of Directors across the globe are struggling to understand how digitalization, the process of becoming a digital business, can be leveraged to achieve the growth they are seeking. However many of these same leaders are focusing primarily on operational efficiency and wonder why they are not seeing the growth results they desire. European business leaders must understand that expanding and diversifying their business model portfolio plays a significant role in realizing growth. In this report, we explain how to deliver on ambitious growth goals by business model innovation and how to move towards the new value-creative asset-light with a blended business model.